The largest database of trusted experimental protocols

5 protocols using blood glucose monitoring system

1

Glucose, Insulin, and AICAR Tolerance in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fasted (14 h) mice were subjected to a glucose tolerance test (GTT) and 5 hr fasted mice were used for an insulin tolerance test (ITT) and AICAR tolerance test (ATT). Mice received glucose (2 g/kg of body weight), insulin (1 U/kg), or AICAR (0.5 g/kg) by intraperitoneal injection. Blood was collected from the tail, and the glucose concentration was determined with blood glucose monitoring system (Bayer).
+ Open protocol
+ Expand
2

Quercetin Treatment for Diabetic Nephropathy

Check if the same lab product or an alternative is used in the 5 most similar protocols
DN rats were randomly divided into three groups: diabetic nephropathy (DN, n = 5), DN treated with low-dose quercetin (DN + LQ, n = 5), and DN treated with high-dose quercetin (DN + HQ, n = 5). Quercetin was administered daily with an oral dose of 50 mg kg−1 (DN + LQ) or 100 mg kg−1 (DN + HQ) 1 week after streptozotocin injection; NC and DN rats were administered vehicle only. Blood glucose was assessed every 2 weeks using a blood glucose monitoring system (Bayer, Leverkusen, Germany) and one drop of tail blood. Body weights were assessed every 2 weeks, and 24 h urine samples were collected in metabolic cages every 4 weeks starting 1 week after streptozotocin injection. All animals were sacrificed at the end of 12 weeks. Blood samples were drawn from the abdominal aorta and serum samples were prepared for assessing renal function by measuring levels of serum creatinine, blood urea nitrogen (BUN), and triglycerides (TG). Kidneys were removed and weighed, and then several fresh renal cortices were fixed in 10% formaldehyde solution and embedded in paraffin for immunohistochemical and histological assays. Small samples of renal cortex were fixed in 2.5% glutaraldehyde for electron microscopic measurements. The remainder of kidneys were snap-frozen and stored at −80 °C for further analysis.
+ Open protocol
+ Expand
3

Liraglutide and Metformin in T2DM with CAD

Check if the same lab product or an alternative is used in the 5 most similar protocols
Drugs used in the study included Liraglutid, 18 mg/3 ml/pen (pre-filled pen), (Novo Nordisk, Beijing, China) and Metformin (Glucophage) 0.5 mg/pill (Shanghai Shiguibao pharmaceutical Co. LTD, Shanghai, China).
All patients were instructed by the investigator for food intake, exercise, drug administration, fingertip blood glucose (FBG) measurement (Bayer Blood Glucose Monitoring System), and records of treatment for hypoglycemia and/or any adverse effects. All preexisting treatment for hypertension, hypercholesterolemia, anticoagulant and coronary dilation were maintained throughout the study. In addition, food intake was controlled and regular exercise was maintained. No drugs that potentially interfered with the outcomes were used. Ultrasound cardiography (UCG) and blood pressure were measured at the hospital.
Two-drug effects on cardiovascular diseases in T2DM patients complicated with CAD were compared between Sections and intra-each Section with glucose and lipid metabolism indicators.
+ Open protocol
+ Expand
4

Calcitriol Attenuates Diabetic Nephropathy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Specific pathogen-free Sprague-Dawley (SD) male rats (180–200 g, 6 weeks old) were provided by the Experimental Animal Center of the Three Gorges University School of Medicine. Animals were given 12 hours of light-darkness cycle at a relative ambient temperature (20 ± 2°C) and a relative air humidity (55 ± 10%) and allowed free access to water and standard rodent food. After one week of adaptation to the environment, the rats were randomly divided into 3 groups: vehicle control group (NC group, n=20), diabetic nephropathy group (DN group, n=20), DN rat treated with Calcitriol group (DN+VD group, n=20). Streptozotocin (STZ) (Sigma, USA) was dissolved in 0.1M citrate buffer (pH 4.4) at a concentration of 4 mg/mL, and a single rapid injection into the intraperitoneal at a dose of 60 mg/kg. The control group was injected an equal amount of 0.1M citrate buffer. Three days later, the randomly rat’s tail vein blood glucose was measured ≥16.7mmol/L considered as diabetes rats, and then which were monitored every two weeks using a blood glucose monitoring system (Bayer). Calcitriol (Roche Company, USA) was dissolved in edible peanut oil at a concentration of 0.04μg/mL and was delivered by oral gavage at a daily dose 0.1 μg/kg after starting at 3 days after STZ injection until sacrifice. The DN group and the control group received an equal amount of edible peanut oil.
+ Open protocol
+ Expand
5

Quantitative Analysis of Antidiabetic Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Voglibose (>98.0%) was purchased from Tokyo Chemical Industries (Tokyo, Japan). Erythromycin, oxytetracycline hydrochloride, cefadroxil, 4-nitrophenyl β-D-glucopyranoside, 4-nitrophenyl β-D-glucuronide, 4-nitrophenyl sulfate, soluble starch, ammonium acetate, streptozotocin, and telmisartan, the internal standard (IS), were purchased from Sigma-Aldrich (St. Louis, MO, USA). High-performance liquid chromatography (HPLC)-grade acetonitrile was purchased from J. T. Bakers (Central Valley, PA, USA). An anaerobe gas generating system was purchased from Becton, Dickinson and Company (Sparks, MD, USA). A blood glucose monitoring system was purchased from Bayer Contour TS (Mishawaka, IN, USA). Potassium phosphate monobasic and potassium phosphate dibasic were purchased from Duksan (Seoul, Korea). All other chemicals were of analytical grades and used as received.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!